JAK1 and diabetes mellitus: Notably, the JAK1/2 inhibitor AZD1480 was effective in preventing insulitis in NOD mice, it prevented HLA-I hyperexpression on their islets and crucially reduced the incidence of spontaneous diabetes (73).